Which early therapy works best for psoriatic arthritis?
NCT ID NCT03739853
First seen Dec 09, 2025 · Last updated May 25, 2026 · Updated 20 times
Summary
This study tested three different treatment strategies for people newly diagnosed with moderate to severe psoriatic arthritis. One group received standard care, another got a combination of disease-modifying drugs early on, and the third started with a stronger biologic drug (TNF inhibitor) early. The goal was to see which approach better controls disease activity and improves outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIATIC ARTHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Oxford University Hospitals NHS Trust
Oxford, Oxfordshire, OX3 7LD, United Kingdom
Conditions
Explore the condition pages connected to this study.